by Garth Sundem | Apr 2, 2020 | Featured, Research
Sabrina Spencer, PhD Cells have a big decision: Should they replicate or sleep? Healthy cells can go either way. Cancer cells’ replication switches are stuck in the ‘on’ position. Now a study by University of Colorado Cancer Center researchers working at CU Boulder’s...
by Garth Sundem | Mar 26, 2020 | Featured, Latest News, Research
Benjamin Bitler, PhD Most ovarian cancer starts in fallopian tubes. Then it sloughs from its site of origin and floats around in fluid until finding new sites of attachment. It’s not easy for cancer cells to survive away from their moorings. Observations by ovarian...
by Garth Sundem | Mar 25, 2020 | Featured, Latest News, Research
Adam Green, MD, CU Cancer Center investigator and pediatric brain cancer specialist at Children’s Hospital Colorado The pediatric brain cancer known as diffuse intrinsic pontine glioma (DIPG) is almost uniformly fatal. In part, this is due to where and how it...
by Garth Sundem | Mar 17, 2020 | Featured, Research
Ryan Weight, DO, MS Immunotherapies have revolutionized the treatment of many cancers. The most common anti-cancer immunotherapies are called checkpoint inhibitors, which block a handshake between the protein PD-L1 on tumor cells and the protein PD-1 on immune system...
by Garth Sundem | Feb 12, 2020 | Featured, Research
Postdoctoral researcher, Michelle Williams, PhD The lab of CU Cancer Center investigator, Jennifer Richer, PhD, has been hot on the trail of new treatments against triple-negative breast cancer (TNBC), an especially dangerous form of the disease. Recently, the lab has...
by Garth Sundem | Jan 30, 2020 | Featured, Research
Ashley Glode, PharmD Chemotherapy used to shrink a tumor before surgery, called neoadjuvant chemotherapy, is becoming more common in many cancers, including stage II and III rectal cancer. However, the chemotherapy regimens FOLFOX and CapeOx used in this setting come...
